Literature DB >> 26609181

RGD PET: From Lesion Detection to Therapy Response Monitoring.

Gang Niu1, Xiaoyuan Chen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26609181      PMCID： PMC5241674          DOI： 10.2967/jnumed.115.168278

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  25 in total

Review 1.  Moyamoya disease.

Authors:  M Fukui; S Kono; K Sueishi; K Ikezaki
Journal:  Neuropathology       Date:  2000-09       Impact factor: 1.906

2.  In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction.

Authors:  Marcus R Makowski; Ullrich Ebersberger; Stephan Nekolla; Markus Schwaiger
Journal:  Eur Heart J       Date:  2008-03-27       Impact factor: 29.983

3.  Pilot study of FPPRGD2 for imaging α(v)β(3) integrin--how integral are integrins?

Authors:  Peter L Choyke
Journal:  Radiology       Date:  2011-07       Impact factor: 11.105

4.  Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts?

Authors:  Samantha Y A Terry; Keelara Abiraj; Jasper Lok; Danny Gerrits; Gerben M Franssen; Wim J G Oyen; Otto C Boerman
Journal:  J Nucl Med       Date:  2014-10-27       Impact factor: 10.057

5.  PET imaging of early response to the tyrosine kinase inhibitor ZD4190.

Authors:  Min Yang; Haokao Gao; Yongjun Yan; Xilin Sun; Kai Chen; Qimeng Quan; Lixin Lang; Dale Kiesewetter; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-01       Impact factor: 9.236

6.  Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?

Authors:  Svetlana N Rylova; Enikö Barnucz; Melpomeni Fani; Friederike Braun; Martin Werner; Silke Lassmann; Helmut R Maecke; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2014-10-02       Impact factor: 10.057

7.  First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination.

Authors:  Weixing Wan; Ning Guo; Donghui Pan; Chunjing Yu; Yuan Weng; Shineng Luo; Hong Ding; Yuping Xu; Lizhen Wang; Lixin Lang; Qingguo Xie; Min Yang; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2013-04-03       Impact factor: 10.057

8.  Alpha-v beta-3 integrin expression in normal and atherosclerotic artery.

Authors:  M Hoshiga; C E Alpers; L L Smith; C M Giachelli; S M Schwartz
Journal:  Circ Res       Date:  1995-12       Impact factor: 17.367

9.  Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD.

Authors:  Roland Haubner; Wolfgang A Weber; Ambros J Beer; Eugenija Vabuliene; Daniel Reim; Mario Sarbia; Karl-Friedrich Becker; Michael Goebel; Rüdiger Hein; Hans-Jürgen Wester; Horst Kessler; Markus Schwaiger
Journal:  PLoS Med       Date:  2005-03-29       Impact factor: 11.069

10.  Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases.

Authors:  Baoming Mi; Chunjing Yu; Donghui Pan; Min Yang; Weixing Wan; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2015-07-12       Impact factor: 11.556
View more
  6 in total

1.  [68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide.

Authors:  Claire Provost; Laura Rozenblum-Beddok; Valérie Nataf; Fatiha Merabtene; Aurélie Prignon; Jean-Noël Talbot
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

2.  Targeting Integrins with Radiolabeled RGD Analogues for Radiotheranostics of Metastatic Radioactive Iodine Nonresponsive Thyroid Cancer: New Avenues in Personalized Medicine.

Authors:  Joanna Klubo-Gwiezdzinska; Xiaoyuan Chen
Journal:  Thyroid       Date:  2020-04       Impact factor: 6.568

3.  Pretreatment PET/CT imaging of angiogenesis based on 18F-RGD tracer uptake may predict antiangiogenic response.

Authors:  Li Li; Li Ma; Dongping Shang; Zhiguo Liu; Qingxi Yu; Suzhen Wang; Xuepeng Teng; Qiang Zhang; Xudong Hu; Wei Zhao; Wenhong Hou; Jianyue Jin; Feng-Ming Spring Kong; Jinming Yu; Shuanghu Yuan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-05       Impact factor: 9.236

4.  Angiogenesis-Targeted 68Ga-DOTA-RGD2 PET/CT Imaging: a Potential Theranostic Application in the Case of Chondrosarcoma.

Authors:  Venkata Subramanian Krishnaraju; Rajender Kumar; Ashwani Sood; Jaya Shukla; Karthikeyan Subramanian; Nandita Kakkar; Naresh Panda; Bhagwant Rai Mittal
Journal:  Nucl Med Mol Imaging       Date:  2021-03-16

5.  18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer.

Authors:  Xiaohui Luan; Yong Huang; Song Gao; Xiaorong Sun; Suzhen Wang; Li Ma; Xuepeng Teng; Hong Lu; Jinming Yu; Shuanghu Yuan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-08       Impact factor: 9.236

Review 6.  Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.

Authors:  Li Li; Xiaoyuan Chen; Jinming Yu; Shuanghu Yuan
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.